Werbung
Werbung

HOTH

HOTH logo

Hoth Therapeutics, Inc. Common Stock

1.08
USD
Gesponsert
-0.02
-1.36%
09. Jan., 14:13 UTC -5
Geschlossen
exchange

Nach-Markt

1.10

+0.02
+1.84%

HOTH Ergebnisberichte

Positives Überraschungsverhältnis

HOTH übertreffen die 12 der letzten 26Schätzungen.

46%

Nächster Bericht

Datum des nächsten Berichts
26. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.10
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
-66.67%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-68.75%

Hoth Therapeutics, Inc. Common Stock earnings per share and revenue

On 12. Nov. 2025, HOTH reported earnings of -0.30 USD per share (EPS) for Q3 25, missing the estimate of -0.10 USD, resulting in a -194.12% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an decrease of -66.67% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Hoth Therapeutics, Inc. Common Stock reported EPS of -$0.30, missing estimates by -194.12%, and revenue of $0.00, 0% as expectations.
The stock price moved down -7.81%, changed from $1.28 before the earnings release to $1.18 the day after.
The next earning report is scheduled for 26. März 2026.
Based on 3 analysts, Hoth Therapeutics, Inc. Common Stock is expected to report EPS of -$0.10 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung